Literature DB >> 1705177

Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer.

T Morita1, A Tokue, N Minato.   

Abstract

In order to analyze the state of the natural resistance system of bladder cancer patients in vivo, we measured natural killer (NK) activity and NK cell subsets of peripheral blood lymphocytes (PBL) from 46 patients with bladder cancer and 25 age- and sex-matched healthy volunteers. The mean NK activity in patients with low-stage bladder cancer was similar to that in the controls, while NK activity in patients with high-stage bladder cancer was significantly depressed. The mean proportions of Leu7+ cells in patients with both low-stage and high-stage bladder cancer were significantly higher than that in the controls. The mean proportion of Leu11 a+ cells in patients with low-stage bladder cancer was similar to that in the controls, while in patients with high-stage bladder cancer it was significantly higher. This study demonstrates the abnormal immunological state of bladder cancer patients: namely, abnormalities exist not only in NK activity but also in the proportions of circulating NK cell subsets.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1705177     DOI: 10.1007/bf01771456

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  19 in total

1.  Immunologic unreactivity in bladder cancer patients.

Authors:  C A Olsson; C N Rao; J O Menzoian; W E Byrd
Journal:  J Urol       Date:  1972-04       Impact factor: 7.450

2.  Natural killer cell activity and response to phytohaemagglutinin compared with the histological diagnosis of patients with transitional cell carcinoma of the bladder.

Authors:  V Britten; R C Rees; A Clegg; G T Smith; C W Potter; M Fox; J L Williams
Journal:  Br J Urol       Date:  1982-06

3.  Natural killer cell activity and head and neck cancer: a clinical assessment.

Authors:  S P Schantz; E J Shillitoe; B Brown; B Campbell
Journal:  J Natl Cancer Inst       Date:  1986-10       Impact factor: 13.506

4.  Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.

Authors:  E H Steinhauer; A T Doyle; J Reed; A S Kadish
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

5.  Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression.

Authors:  M Takasugi; A Ramseyer; J Takasugi
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

6.  Clinical application of a whole blood assay for human natural killer (NK) cell activity.

Authors:  A Morales; P C Ottenhof
Journal:  Cancer       Date:  1983-08-15       Impact factor: 6.860

7.  Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life.

Authors:  T Abo; C A Miller; G L Gartland; C M Balch
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

8.  Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice.

Authors:  N Minato; B R Bloom; C Jones; J Holland; L M Reid
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

9.  On the heterogeneity of murine natural killer cells.

Authors:  N Minato; L Reid; B R Bloom
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes.

Authors:  L L Lanier; S Cwirla; N Federspiel; J H Phillips
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.

Authors:  Chrysoula I Liakou; Sowmita Narayanan; Derek Ng Tang; Christopher J Logothetis; Padmanee Sharma
Journal:  Cancer Immun       Date:  2007-06-26

2.  Smoking-induced immune deviation contributes to progression of bladder and other cancers.

Authors:  Jessica M Clement; Fei Duan; Pramod K Srivastava
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

3.  The association between the recurrence of solitary non-muscle invasive bladder cancer and tumor infiltrating lymphocytes.

Authors:  Kristian Krpina; Emina Babarović; Gordana Dorđević; Zeljko Fuckar; Nives Jonjić
Journal:  Croat Med J       Date:  2012-12       Impact factor: 1.351

4.  Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.

Authors:  Christine V Ichim
Journal:  J Transl Med       Date:  2005-02-08       Impact factor: 5.531

5.  Cancer risk in patients with alopecia areata: a nationwide population-based matched cohort study.

Authors:  Chih-Chiang Chen; Yun-Ting Chang; Han-Nan Liu; Yi-Ju Chen
Journal:  Cancer Med       Date:  2018-03-25       Impact factor: 4.452

6.  Do Orthotopic Ileal Diversions Induce Immunological Changes in Retained Urethral Tissue?

Authors:  Günter Niegisch; Christina Hulsbergen-van de Kaa; Martine Ploeg; Kees Hendricksen; J Alfred Witjes
Journal:  Bladder Cancer       Date:  2015-04-30

7.  An essential role for decorin in bladder cancer invasiveness.

Authors:  Mohamed El Behi; Sophie Krumeich; Catalina Lodillinsky; Aurélie Kamoun; Lorenzo Tibaldi; Gaël Sugano; Aurélien De Reynies; Elodie Chapeaublanc; Agnès Laplanche; Thierry Lebret; Yves Allory; François Radvanyi; Olivier Lantz; Ana María Eiján; Isabelle Bernard-Pierrot; Clotilde Théry
Journal:  EMBO Mol Med       Date:  2013-10-20       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.